Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
J Neurointerv Surg. 2013 May;5 Suppl 1(0 1):i44-7. doi: 10.1136/neurintsurg-2011-010240. Epub 2012 May 18.
Strategies for patient selection for intra-arterial therapy (IAT) in acute ischemic stroke (AIS) are highly variable. The degree of protocol adoption and treatment rates associated with implementation of a service-wide patient selection IAT protocol were assessed.
All patients with AIS prospectively recorded in our stroke database from January 2007 to June 2009 were reviewed. The IAT patient selection protocol was implemented in March 2008. Patients were defined as likely to benefit (LTB) from IAT if they had brain imaging completed within 6 h from last known well time, NIH Stroke Scale score ≥ 8, infarct volume ≤ 100 ml and evidence of proximal artery occlusion.
Of 1348 subjects identified, 118 (8.7%) met the criteria for LTB and 62 (52%) underwent IAT. There was a significant increase in rates of IAT among LTB patients after protocol implementation (61% vs 40%, p<0.02). In LTB patients, factors associated with IAT were stroke duration (OR 0.78, 95% CI 0.6 to 0.9 per hour), arrival within later calendar months during study period (OR 1.1, 95% CI 1.02 to 1.2 per month), intravenous tissue plasminogen activator (OR 0.6, 95% CI 0.4 to 0.9) and age (OR 0.98, 95% CI 0.95 to 1.02 per year). After multivariable adjustment, only stroke duration (OR 0.65, 95% CI 0.5 to 0.8 per hour) remained an independent predictor of IAT.
Most patients with AIS did not meet our criteria for LTB and only 52% of those defined as LTB received IAT. Protocol adoption increased the use of IAT over time; however, further exploration of factors associated with the reasons for non-treatment and the impact of IAT on outcomes is necessary.
急性缺血性脑卒中(AIS)患者进行动脉内治疗(IAT)的选择策略存在较大差异。本研究评估了采用广泛患者选择 IAT 方案的程度和治疗率。
回顾 2007 年 1 月至 2009 年 6 月前瞻性记录在我们卒中数据库中的所有 AIS 患者。2008 年 3 月实施 IAT 患者选择方案。如果患者的脑部影像学检查在最后一次已知健康时间后 6 小时内完成、美国国立卫生研究院卒中量表(NIHSS)评分≥8 分、梗死体积≤100ml 且存在近端动脉闭塞,则定义为可能从 IAT 中获益(LTB)。
共纳入 1348 例患者,其中 118 例(8.7%)符合 LTB 标准,62 例(52%)进行了 IAT。方案实施后,LTB 患者的 IAT 治疗率显著增加(61%比 40%,p<0.02)。在 LTB 患者中,与 IAT 相关的因素包括卒中持续时间(OR 0.78,95%CI 0.6 至 0.9 每小时)、研究期间较晚的日历月到达(OR 1.1,95%CI 1.02 至 1.2 每月)、静脉组织型纤溶酶原激活物(OR 0.6,95%CI 0.4 至 0.9)和年龄(OR 0.98,95%CI 0.95 至 1.02 每年)。多变量调整后,仅卒中持续时间(OR 0.65,95%CI 0.5 至 0.8 每小时)仍是 IAT 的独立预测因素。
大多数 AIS 患者不符合我们的 LTB 标准,仅有 52%的 LTB 患者接受了 IAT。随着时间的推移,方案的采用增加了 IAT 的使用;然而,需要进一步探讨与未治疗相关的因素以及 IAT 对结局的影响。